JSPR Jasper Therapeutics Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: JSPR

Price (delayed)

$24.52

Market cap

$369.37M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$6.18

Enterprise value

$284.85M

Highlights
The EPS is up by 40% year-on-year and by 26% since the previous quarter
JSPR's debt is down by 24% YoY and by 8% QoQ
JSPR's equity has surged by 118% year-on-year but it is down by 17% since the previous quarter
JSPR's quick ratio is up by 27% year-on-year but it is down by 19% since the previous quarter
Jasper Therapeutics's net income has shrunk by 71% YoY and by 6% QoQ
Sector: Healthcare
Industry: Biotechnology
Peers: OPTN OPK ORGO

Key stats

What are the main financial stats of JSPR
Market
Shares outstanding
15.06M
Market cap
$369.37M
Enterprise value
$284.85M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
3.49
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$64.47M
EBITDA
-$62.94M
Free cash flow
-$52.33M
Per share
EPS
-$6.18
Free cash flow per share
-$5.01
Book value per share
$7.03
Revenue per share
$0
TBVPS
$9.09
Balance sheet
Total assets
$94.89M
Total liabilities
$16.45M
Debt
$2.79M
Equity
$78.44M
Working capital
$76.56M
Liquidity
Debt to equity
0.04
Current ratio
7.19
Quick ratio
7.06
Net debt/EBITDA
1.34
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-55.1%
Return on equity
-63.2%
Return on invested capital
-13,395.3%
Return on capital employed
-78.1%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

JSPR stock price

How has the Jasper Therapeutics stock price performed over time
Intraday
2.25%
1 week
20.2%
1 month
-9.52%
1 year
87.18%
YTD
210.77%
QTD
-16.49%

Financial performance

How have Jasper Therapeutics's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$68.86M
Net income
-$64.47M
Gross margin
N/A
Net margin
N/A
Jasper Therapeutics's net income has shrunk by 71% YoY and by 6% QoQ
The operating income has declined by 35% year-on-year and by 6% since the previous quarter

Growth

What is Jasper Therapeutics's growth rate over time

Valuation

What is Jasper Therapeutics stock price valuation
P/E
N/A
P/B
3.49
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS is up by 40% year-on-year and by 26% since the previous quarter
The price to book (P/B) is 191% higher than the last 4 quarters average of 1.2
JSPR's equity has surged by 118% year-on-year but it is down by 17% since the previous quarter

Efficiency

How efficient is Jasper Therapeutics business performance
The company's return on equity rose by 12% YoY and by 6% QoQ
The company's return on assets rose by 5% YoY and by 5% QoQ

Dividends

What is JSPR's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for JSPR.

Financial health

How did Jasper Therapeutics financials performed over time
JSPR's total assets has soared by 96% year-on-year but it is down by 14% since the previous quarter
The company's total liabilities rose by 33% YoY
JSPR's debt is 96% lower than its equity
JSPR's equity has surged by 118% year-on-year but it is down by 17% since the previous quarter
The debt to equity has dropped by 60% year-on-year but it is up by 33% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.